Zacks Investment Research on MSN
ImmunityBio shares surge on updated durable lymphoma study results
Shares of ImmunityBio IBRX surged 39.8% on Friday and added a further 9.4% in after-hours trading after the company reported ...
Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided feedback received from the ...
Background While female sex has historically been associated with worse outcomes following surgical aortic valve replacement, ...
In August 2026, Gradone and Selden will lead a 28-day expedition aboard the R/V Falkor (too), a state-of-the-art research ...
Clinician-scientists at the University of Pittsburgh School of Medicine have developed an artificial intelligence (AI) tool ...
Scheimpflug-based pachymetry may inaccurately suggest corneal thinning after accelerated corneal crosslinking.
ImmunityBio (IBRX) announced results from its Anktiva clinical program in non-small cell lung cancer based on two studies, ...
Natural appetite suppressants include fenugreek, glucomannan, coffee, green tea, and foods high in fiber, protein, and water.
On January 14, Liz Ann Sonders from Charles Schwab appeared on a CNBC Television interview to discuss the market volatility, ...
Microsoft alone runs approximately 100,000 A/B tests each year to continuously optimize products. A famous Gmail experiment, ...
Introduction With the increasing prevalence of asthma in children, exercise has become an essential component of asthma management, playing a significant role in improving overall health and quality ...
In BREAKWATER, EC plus FOLFIRI achieved a 64.4% response rate and showed a trend toward improved overall survival in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results